Mostrando resultados 18 a 28 de 28
< Anterior
Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
closedAccess | | 2016 | Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group | Martín, Alejandro; Redondo, Alba; Dlouhy, Iván; Salar, Antonio; González-Barca, Eva; Canales, Miguel; Montes-Moreno, Santiago; Ocio, Enrique M. CSIC ORCID ; López-Guillermo, Armando; Caballero, Maria Dolores | artículo |
closedAccess | | 2010 | Liver function tests and absolute lymphocyte count at day +100 are predictive factors for extensive and severe chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant | Silva, Fernando; Pérez-Simón, José A. CSIC ORCID; Caballero-Velázquez, Teresa CSIC ORCID; Encinas, Cristina; Sánchez-Guijo, Fermín M. CSIC ORCID; Díez-Campelo, María; Colado, Enrique; Martín, Jesús; Villanueva-Gómez, Fernanda; Vázquez, Lourdes; Cañizo, María Consuelo del; Caballero, Maria Dolores; San Miguel, Jesús F. CSIC ORCID | artículo |
openAccess | | 26-ago-2020 | Measures to maintain a SARS-CoV-2 negative inpatient hematological unit in the midst of the COVID-19 pandemic | Cabero-Martínez, Almudena; Sánchez-Guijo, Fermín M. CSIC ORCID; López-Corral, L.; Pérez-López, Estefanía; Avendaño, Alejandro; Baile, Mónica; Cabrero, Mónica; Martín, Ana-África; Rodríguez, Ángela; Pérez, Balbina; Peña-Muñoz, Felipe; Román, Luz-Gema; Palomino, Danylo; López-Vázquez, Lourdes; Vidriales, Maria Belén; González, Marcos CSIC ORCID ; Mateos, Maria Victoria; Caballero, Maria Dolores | artículo |
closedAccess | | 2012 | Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: Antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype | Sebastián, Elena; Alcoceba, Miguel; Balanzategui, Ana; Flores, Teresa; González, David; Sarasquete, María Eugenia; Chillón, M. del Carmen; Caballero, Maria Dolores; San Miguel, Jesús F. CSIC ORCID; García-Sanz, Ramón; González, Marcos CSIC ORCID | artículo |
closedAccess | | 2013 | Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients | Caballero-Velázquez, Teresa CSIC ORCID; López-Corral, L.; Encinas, Cristina; Caballero, Maria Dolores; San Miguel, Jesús F. CSIC ORCID; Pérez-Simón, José A. CSIC ORCID | artículo |
closedAccess | | 2008 | Prognostic Factors of Chronic Graft-versus-Host Disease Following Allogeneic Peripheral Blood Stem Cell Transplantation: The National Institutes Health Scale Plus the Type of Onset Can Predict Survival Rates and the Duration of Immunosuppressive Therapy | Pérez-Simón, José A. CSIC ORCID; Encinas, Cristina; Silva, Fernando; Arcos, Maria José; Díez-Campelo, María; Sánchez-Guijo, Fermín M. CSIC ORCID; Colado, Enrique; Martín, Jesús; Vázquez, Lourdes; Cañizo, María Consuelo del; Caballero, Maria Dolores; San Miguel, Jesús F. CSIC ORCID | artículo |
closedAccess | | sep-2019 | Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma | López-Corral, L.; Caballero-Velázquez, Teresa CSIC ORCID; López-Godino, Oriana; Rosiñol, Laura; Pérez-Vicente, Sabina CSIC; Fernández-Avilés, Francisco; Krsnik, Isabel; Morillo, Daniel; Heras, Inmaculada; Morgades, Mireia; Rifon, Jose J.; Sampol, Antonia; Iniesta, Francisca; Ocio, Enrique M. CSIC ORCID ; Martín, Jesús; Rovira, Montserrat; Cabero, Martín; Castilla-Llorente, Cristina; Ribera, Josep-Maria; Torres-Juan, Marta; Moraleda, José María; Martínez, Carmen; Vázquez, Alejandro; Gutiérrez, Gonzalo; Caballero, Maria Dolores; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria; Pérez-Simón, José A. CSIC ORCID | artículo |
openAccess | | 2014 | Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus | Labrador, Jorge; López-Corral, L.; Vázquez-López, Lourdes; Díez-Campelo, María; Sánchez-Guijo, Fermín M. CSIC ORCID; Pérez-López, Estefanía; Guerrero Arroyo, María del Carmen CSIC ORCID ; Cañizo, María Consuelo del; Pérez-Simón, José A. CSIC ORCID; González-Porras, José R.; Caballero, Maria Dolores | artículo |
openAccess | | 2020 | Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study | Escamilla-Gómez, Virginia CSIC ORCID; López-Corral, L.; García-Cadenas, Irene; Márquez-Malaver, Francisco José; Caballero-Velázquez, Teresa CSIC ORCID; Calderón-Cabrera, Cristina CSIC; Rodríguez Torres, Nancy; Ferrá, Christelle; Valcárcel, David; Mende, María João; Caballero, Maria Dolores; Pérez-López, Estefanía; Martino, Rodrigo; Sierra, Jorge; Zudaire Ripa, Teresa; Pérez-Simón, José A. CSIC ORCID | artículo |
openAccess | | 2011 | Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation | Caballero, Maria Dolores; Alcoceba, Miguel; Balanzategui, Ana; Sarasquete, María Eugenia; García-Sanz, Ramón; González, Marcos CSIC ORCID | artículo |
closedAccess | | 2017 | The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy | Alonso-Álvarez, Sara; Vidriales, Maria Belén; Caballero, Maria Dolores; Blanco, Óscar; Puig, Noemi; Martín, Alejandro; Peñarrubia, María J.; Zato, Esther; Galende, Josefina; Bárez, Abelardo; Alcoceba, Miguel; Orfao, Alberto CSIC ORCID ; González, Marcos CSIC ORCID ; García-Sanz, Ramón | artículo |